Dr. Rama Amara and colleagues report that a treatment under development appears to stop the equivalent of the AIDS virus in monkeys. The treatment appears to work by preventing virus cells from fooling the immune system.

Learn more about this exciting new study as reported in the journal Nature, and by Forbes, US News and World Report, and Health Day . <MORE>

________________________________________________________

UPDATE:  Phase 2a Human Clinical trials are beginning at Emory's HOPE Clinic and elsewhere across the country for Dr. Harriet Robinson's promising AIDS vaccine.

The vaccine developed at the Emory Vaccine Center has moved into Phase 2a Clinical Trials. It is being manufactured and tested through Atlanta-based biotechnology firm GeoVax and has been shipped to HIV Vaccine Trials Network (HVTN) for use in the Phase 2a Trial. <MORE> To learn more about the clinical trials or to enroll as a volunteer, click HERE.